[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR2320107A1 - Nouveaux adjuvants immunologiques, procede pour leur obtention et compositions les contenant - Google Patents

Nouveaux adjuvants immunologiques, procede pour leur obtention et compositions les contenant

Info

Publication number
FR2320107A1
FR2320107A1 FR7524440A FR7524440A FR2320107A1 FR 2320107 A1 FR2320107 A1 FR 2320107A1 FR 7524440 A FR7524440 A FR 7524440A FR 7524440 A FR7524440 A FR 7524440A FR 2320107 A1 FR2320107 A1 FR 2320107A1
Authority
FR
France
Prior art keywords
obtaining
compositions containing
immunological adjuvants
new immunological
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7524440A
Other languages
English (en)
Other versions
FR2320107B1 (fr
Inventor
Pierre Jolles
Daniel Migliore Samour
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bpifrance Financement SA
Original Assignee
Agence National de Valorisation de la Recherche ANVAR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agence National de Valorisation de la Recherche ANVAR filed Critical Agence National de Valorisation de la Recherche ANVAR
Priority to FR7524440A priority Critical patent/FR2320107A1/fr
Priority to BE169371A priority patent/BE844672A/fr
Priority to SE7608640A priority patent/SE7608640L/xx
Priority to IL50187A priority patent/IL50187A0/xx
Priority to GB32081/76A priority patent/GB1525763A/en
Priority to DE19762634904 priority patent/DE2634904A1/de
Priority to US05/711,193 priority patent/US4110434A/en
Priority to LU75522A priority patent/LU75522A1/xx
Priority to NL7608680A priority patent/NL7608680A/xx
Priority to DK352276A priority patent/DK352276A/da
Priority to JP51093095A priority patent/JPS5234917A/ja
Publication of FR2320107A1 publication Critical patent/FR2320107A1/fr
Application granted granted Critical
Publication of FR2320107B1 publication Critical patent/FR2320107B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/005Glycopeptides, glycoproteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/5555Muramyl dipeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55583Polysaccharides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/32Mycobacterium
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/27Cyclic peptide or cyclic protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR7524440A 1975-08-05 1975-08-05 Nouveaux adjuvants immunologiques, procede pour leur obtention et compositions les contenant Granted FR2320107A1 (fr)

Priority Applications (11)

Application Number Priority Date Filing Date Title
FR7524440A FR2320107A1 (fr) 1975-08-05 1975-08-05 Nouveaux adjuvants immunologiques, procede pour leur obtention et compositions les contenant
BE169371A BE844672A (fr) 1975-08-05 1976-07-29 Nouveaux immonologiques, procede pour leur obtention et compositions les contenant
SE7608640A SE7608640L (sv) 1975-08-05 1976-07-30 Nya immunologiska adjuvantia, forfarande for framtellning derav samt kompositioner innehallande desamma
GB32081/76A GB1525763A (en) 1975-08-05 1976-08-02 Immunological adjuvants process for their production and compositions containing them
IL50187A IL50187A0 (en) 1975-08-05 1976-08-02 Novel immunological adjuvants their production and compositions containing them
US05/711,193 US4110434A (en) 1975-08-05 1976-08-03 Novel immunological adjuvants, process for their production and compositions containing them
DE19762634904 DE2634904A1 (de) 1975-08-05 1976-08-03 Neue immunologische adjuvantien, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
LU75522A LU75522A1 (fr) 1975-08-05 1976-08-03
NL7608680A NL7608680A (nl) 1975-08-05 1976-08-04 Werkwijze voor het bereiden van nieuwe immunologische ondersteuningsmiddelen.
DK352276A DK352276A (da) 1975-08-05 1976-08-04 Immunologiske adjuvanser og fremgangsmade til fremstilling deraf
JP51093095A JPS5234917A (en) 1975-08-05 1976-08-04 Novel immunological medicine * production thereof and composition containing same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7524440A FR2320107A1 (fr) 1975-08-05 1975-08-05 Nouveaux adjuvants immunologiques, procede pour leur obtention et compositions les contenant

Publications (2)

Publication Number Publication Date
FR2320107A1 true FR2320107A1 (fr) 1977-03-04
FR2320107B1 FR2320107B1 (fr) 1980-01-11

Family

ID=9158793

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7524440A Granted FR2320107A1 (fr) 1975-08-05 1975-08-05 Nouveaux adjuvants immunologiques, procede pour leur obtention et compositions les contenant

Country Status (11)

Country Link
US (1) US4110434A (fr)
JP (1) JPS5234917A (fr)
BE (1) BE844672A (fr)
DE (1) DE2634904A1 (fr)
DK (1) DK352276A (fr)
FR (1) FR2320107A1 (fr)
GB (1) GB1525763A (fr)
IL (1) IL50187A0 (fr)
LU (1) LU75522A1 (fr)
NL (1) NL7608680A (fr)
SE (1) SE7608640L (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994016727A1 (fr) * 1993-01-29 1994-08-04 Vetrepharm, Inc. Composition immunotherapeutique

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU727647A1 (ru) * 1977-11-02 1980-04-15 Институт биоорганической химии им.М.М.Шемякина Гликопептиды,обладающие противоопухолевой активностью и способ их получени
US4397844A (en) * 1978-02-24 1983-08-09 Ciba-Geigy Corporation Antigen derivatives and processes for their preparation
US4313934A (en) * 1979-05-08 1982-02-02 Kirin Beer Kabushiki Kaisha Physiologically active polysaccharides, production and uses thereof
JPS59116681A (ja) * 1982-12-23 1984-07-05 セイコーインスツルメンツ株式会社 液晶表示装置
US4897256A (en) * 1986-11-25 1990-01-30 Abbott Laboratories LHRH analog formulations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL2816C (fr) *
US3429868A (en) * 1956-03-12 1969-02-25 Kiyoshi Kominato Method of preparing a series of prosthetic groups and coenzymes of a new redox-enzyme which are present in plants,animals,or foods and have vitamin-like activity
NL7308450A (fr) * 1972-06-20 1973-12-27
US3941762A (en) * 1973-05-07 1976-03-02 E. R. Squibb & Sons, Inc. O-acyl derivatives of antibiotic EM-49
FR2269961B1 (fr) * 1974-05-06 1978-03-24 Anvar
US3992528A (en) * 1975-02-18 1976-11-16 Research Corporation Anti-viral substance containing peptide, fatty acid and carbohydrate moieties

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994016727A1 (fr) * 1993-01-29 1994-08-04 Vetrepharm, Inc. Composition immunotherapeutique
US5759554A (en) * 1993-01-29 1998-06-02 Vetrepharm, Inc. Immunostimulatory bacterial cell wall traction

Also Published As

Publication number Publication date
JPS5234917A (en) 1977-03-17
SE7608640L (sv) 1977-02-06
NL7608680A (nl) 1977-02-08
DE2634904A1 (de) 1977-02-10
LU75522A1 (fr) 1977-03-25
IL50187A0 (en) 1976-10-31
GB1525763A (en) 1978-09-20
US4110434A (en) 1978-08-29
FR2320107B1 (fr) 1980-01-11
BE844672A (fr) 1976-11-16
DK352276A (da) 1977-02-06

Similar Documents

Publication Publication Date Title
BE877596A (fr) Nouvelles oxybenzylidene bornanones, procede pour leur preparation et compositions cosmetiques les contenant
FR2332321A1 (fr) Adjuvants pour detergents et procede pour leur preparation
FR2327763A1 (fr) Composition antisudorifique et procede pour son obtention
BE879381A (fr) Nouveaux indoles, leur preparation et compositions les contenant
FR2331340A1 (fr) Nouveaux derives du benzimidazole, procede pour leur obtention et compositions pharmaceutiques les contenant
FR2328508A1 (fr) Gels poreux, leur procede d'obtention et applications
FR2296616A1 (fr) Nouvelles acyldiamines et procede pour leur obtention
BE853733A (fr) Nouveaux nitroaminophenols substitues, leur procede d'obtention et compositions tinctoriales les contenant
FR2300089A1 (fr) Nouveaux multiheteromacrocycles contenant au moins un radical pyridyle et leur procede de preparation
BE877595A (fr) Nouveaux prostenoides et procede pour leur preparation
BE856854A (fr) Nouveaux oligomeres tensio-actifs sequences, procede pour les preparer et composition les contenant
FR2408593B1 (fr) Nouvelles triazines et procede pour leur preparation
BE815122A (fr) Nouvelles 1,3-oxazino (5,6-c) rifamycines et procede pour leur obtention.
BE856853A (fr) Nouveaux oligomeres tensio-actifs sequences, du type polyethers polyhydroxyles, procede pour les preparer et composition les contenant
BE845317A (fr) Nouveaux procede de preparation d'azines
BE885268A (fr) Nouveaux n-propionyl-sarcosine-anilides, procede pour leur preparation et medicaments les contenant
BE844066A (fr) Nouveaux ethers de 2', 3,6'-trichloro-4-cyano-4'-benzoylureidodiphenyle, leur procede de preparation et leur application
BE844666A (fr) Derives de thiazolidine, procede pour leur obtention et compositions les contenant
FR2320107A1 (fr) Nouveaux adjuvants immunologiques, procede pour leur obtention et compositions les contenant
BE809179A (fr) Nouvelles cyclopropylamines, leur procede d'obtention et les compositions pharmaceutiques en contenant
BE877664A (fr) Nouveaux oligomeres statistiques tensio-actifs, procede pour leur preparation et compositions les contenant
FR2499102B1 (fr) Nouvelles compositions dures, melanges precurseurs et procedes pour leur preparation
FR2349643A1 (fr) Complexes contenant du magnesium, procede pour leur preparation et compositions les contenant
FR2286643A1 (fr) Nouveaux triiodocarbanilates, leur procede de preparation et composition pharmaceutique les contenant
FR2304343A1 (fr) Nouvelles cephalosporines, procede pour leur obtention et compositions pharmaceutiques les contenant

Legal Events

Date Code Title Description
ST Notification of lapse